KLLN 抗体
(Killin, p53-Regulated DNA Replication Inhibitor (KLLN))
DNA-binding protein involved in S phase checkpoint control-coupled apoptosis by mediating p53/TP53-induced apoptosis. Has the ability to inhibit DNA synthesis and S phase arrest coupled to apoptosis. Has affinity to both double- and single- stranded DNA.
Recommended next Filters:
您想试用我们的人工智能搜索吗？
21 results
Latest Publications for our KLLN 抗体
: "Nuclear KLLN expression associates with improved relapse-free survival for prostate carcinoma." in: Endocrine-related cancer, Vol. 21, Issue 4, pp. 579-86, (2014) (PubMed).: "Activation of AR sensitizes breast carcinomas to NVP-BEZ235's therapeutic effect mediated by PTEN and KLLN upregulation." in: Molecular cancer therapeutics, Vol. 13, Issue 2, pp. 517-27, (2014) (PubMed).
: "Androgen receptor-induced tumor suppressor, KLLN, inhibits breast cancer growth and transcriptionally activates p53/p73-mediated apoptosis in breast carcinomas." in: Human molecular genetics, Vol. 22, Issue 11, pp. 2263-72, (2013) (PubMed).
Aliases for KLLN 抗体
killin, p53-regulated DNA replication inhibitor (KLLN) 抗体CWS4 抗体
KILLIN 抗体
您还需要查找其他产品吗？
You are here:
